N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141875 |
| CAS No | NA |
| Mol.F. | C34H43N5O4 |
| Mol.Wt. | 585.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141876 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141877 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141878 |
| CAS No | NA |
| Mol.F. | C30H36N6O4 |
| Mol.Wt. | 544.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141879 |
| CAS No | NA |
| Mol.F. | C21H16IN3O2 |
| Mol.Wt. | 469.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141880 |
| CAS No | NA |
| Mol.F. | C12H13N5O2 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141881 |
| CAS No | NA |
| Mol.F. | C24H28N4O3 |
| Mol.Wt. | 420.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141882 |
| CAS No | NA |
| Mol.F. | C12H23N3O4 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141883 |
| CAS No | NA |
| Mol.F. | C11H21N3O4 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141884 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141885 |
| CAS No | NA |
| Mol.F. | C13H18N2O2 |
| Mol.Wt. | 234.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141886 |
| CAS No | NA |
| Mol.F. | C22H18N4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141887 |
| CAS No | NA |
| Mol.F. | C22H16N4O5 |
| Mol.Wt. | 416.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141888 |
| CAS No | NA |
| Mol.F. | C23H20N4O3 |
| Mol.Wt. | 400.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141889 |
| CAS No | NA |
| Mol.F. | C27H23N5O6 |
| Mol.Wt. | 513.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141890 |
| CAS No | NA |
| Mol.F. | C21H16N4O3 |
| Mol.Wt. | 372.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |